CSW Stock Analysis: CSW Industrials | NYSE
Specialty Industrial Machinery | NYSE, USA | Market Cap: 4.671m USD | 12M Return: 15.4% | US1264021064 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 36.7M
EPS Trend: 96.9%
Qual. Beats: 0
Rev. Trend: 96.9%
Warnings
Tailwinds
No distinct edge detected
Seasonality 11 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
CSW Industrials (NYSE: CSW) is a Dallas, Texas-based diversified industrial products manufacturer operating through three reportable segments: Contractor Solutions (HVAC installation, condensate management, refrigerant accessories, and ductless mini-split support products), Engineered Building Solutions (architectural railings, expansion joints, fire/smoke curtains, and fire-stopping products), and Specialized Reliability Solutions (industrial compounds, lubricants, sealants, and filtration products). The company markets an extensive portfolio of specialty brands-including RectorSeal, MARS, TRUaire, Balco, Smoke Guard, Whitmore, Jet-Lube, and Hydrotex-across the Americas, Europe, the Middle East and Africa, and the Asia Pacific region. CSW was incorporated in 2014.
Classified within the Industrials sector and the Building Products sub-industry, CSW follows a brand-aggregation model in which it acquires and operates niche-leading product lines serving both new construction and maintenance, repair, and operations (MRO) end markets. This multi-segment structure allows the company to address distinct customer bases-from HVAC contractors and commercial builders to heavy-industrial maintenance operators-while diversifying exposure across the building and infrastructure lifecycle.
- AIM Act refrigerant phaseout boosts HVAC contractor product demand
- Residential and commercial construction cycles drive segment revenue
- Serial M&A strategy expands margins and product portfolio
| Net Income: 120.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -3.60 > 1.0 |
| NWC/Revenue: 33.16% < 20% (prev 32.01%; Δ 1.15% < -1%) |
| CFO/TA 0.07 > 3% & CFO 164.6m > Net Income 120.9m |
| Net Debt (883.4m) to EBITDA (281.4m): 3.14 < 3 |
| Current Ratio: 2.70 > 1.5 & < 3 |
| Outstanding Shares: last quarter (16.4m) vs 12m ago -2.93% < -2% |
| Gross Margin: 42.38% > 18% (prev 43.82%; Δ -1.45% > 0.5%) |
| Asset Turnover: 60.45% > 50% (prev 59.62%; Δ 0.83% > 0%) |
| Interest Coverage Ratio: 6.11 > 6 (EBIT TTM 207.4m / Interest Expense TTM 34.0m) |
| A: 0.17 (Total Current Assets 616.0m - Total Current Liabilities 228.1m) / Total Assets 2.33b |
| B: 0.36 (Retained Earnings 843.8m / Total Assets 2.33b) |
| C: 0.11 (EBIT TTM 207.4m / Avg Total Assets 1.93b) |
| D: 0.87 (Book Value of Equity 1.07b / Total Liabilities 1.24b) |
| Altman-Z'' = 3.90 = AA |
| DSRI: 1.02 (Receivables 233.3m/179.4m, Revenue 1.17b/915.8m) |
| GMI: 1.03 (GM 43.82% / 42.38%) |
| AQI: 1.16 (AQ_t 0.69 / AQ_t-1 0.59) |
| SGI: 1.28 (Revenue 1.17b / 915.8m) |
| TATA: -0.02 (NI 120.9m - CFO 164.6m) / TA 2.33b) |
| Beneish M = -2.69 (Cap -4..+1) = A |
As of October 09, 2026, the stock is trading at USD 286.62 with a total of 126,549 shares traded. Over the past week, the price has changed by -1.97%, over one month by -5.39%, over three months by +5.71% and over the past year by +15.35%.
Current recommended Stop Loss: 273.00 (which is 4.8% or 1.4 ATR below the current price).
CSW Industrials has received a consensus analysts rating of 3.57. Therefore, it is recommended to hold CSW.
- StrongBuy: 1
- Buy: 2
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 351.9 | 22.8% |
P/E Trailing = 40.6667
P/E Forward = 42.5532
P/S = 3.9941
P/B = 4.5215
P/EG = 2.8426
Revenue TTM = 1.17b USD
EBIT TTM = 207.4m USD
EBITDA TTM = 281.4m USD
Long Term Debt = 826.0m USD (from longTermDebt, last quarter)
Short Term Debt = 29.5m USD (from shortTermDebt, last quarter)
Debt = 930.9m USD (from shortLongTermDebtTotal, last quarter) + Leases 75.5m
Net Debt = 883.4m USD (calculated: Debt 930.9m - CCE 47.5m)
Enterprise Value = 5.55b USD (4.67b + Debt 930.9m - CCE 47.5m)
Interest Coverage Ratio = 6.11 (Ebit TTM 207.4m / Interest Expense TTM 34.0m)
EV/FCF = 38.50x (Enterprise Value 5.55b / FCF TTM 144.3m)
FCF Yield = 2.60% (FCF TTM 144.3m / Enterprise Value 5.55b)
FCF Margin = 12.34% (FCF TTM 144.3m / Revenue TTM 1.17b)
Net Margin = 10.33% (Net Income TTM 120.9m / Revenue TTM 1.17b)
Gross Margin = 42.38% ((Revenue TTM 1.17b - Cost of Revenue TTM 674.0m) / Revenue TTM)
Gross Margin QoQ = 44.88% (prev 40.98%)
Tobins Q-Ratio = 2.38 (Enterprise Value 5.55b / Total Assets 2.33b)
Interest Expense / Debt = 3.65% (Interest Expense 34.0m / Debt 930.9m)
Taxrate = 23.17% (36.6m / 158.1m)
NOPAT = 159.4m (EBIT 207.4m * (1 - 23.17%))
Current Ratio = 2.70 (Total Current Assets 616.0m / Total Current Liabilities 228.1m)
Debt / Equity = 0.87 (Debt 930.9m / totalStockholderEquity, last quarter 1.07b)
Debt / EBITDA = 3.14 (Net Debt 883.4m / EBITDA 281.4m)
Debt / FCF = 6.12 (Net Debt 883.4m / FCF TTM 144.3m)
Total Stockholder Equity = 1.08b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.25% (Net Income 120.9m / Total Assets 2.33b)
RoE = 11.19% (Net Income TTM 120.9m / Total Stockholder Equity 1.08b)
RoCE = 10.88% (EBIT 207.4m / Capital Employed (Equity 1.08b + L.T.Debt 826.0m))
RoIC = 7.64% (NOPAT 159.4m / Invested Capital 2.09b)
WACC = 10.20% (E(4.67b)/V(5.60b) * Re(11.67%) + D(930.9m)/V(5.60b) * Rd(3.65%) * (1-Tc(0.23)))
Discount Rate = 11.67% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 68.08 | Cagr: 2.19%
[DCF] Terminal Value 68.59% ; FCFF base≈146.7m ; Y1≈142.4m ; Y5≈140.9m
[DCF] Fair Price = 49.10 (EV 1.68b - Net Debt 883.4m = Equity 800.1m / Shares 16.3m; r=10.20% [WACC]; 5y FCF grow -4.00% → 2.50% )
EPS Correlation: 96.88 | EPS CAGR: 22.00% | SUE: 0.46 | # QB: 0
Revenue Correlation: 96.91 | Revenue CAGR: 15.49% | SUE: N/A | # QB: 0
EPS current Quarter (2026-09-30): EPS=3.63 | Chg30d=+0.00% | Revisions=+30% | Analysts=7
EPS next Quarter (2026-12-31): EPS=1.84 | Chg30d=+0.00% | Revisions=-10% | Analysts=7
EPS current Year (2027-03-31): EPS=12.59 | Chg30d=+0.00% | Revisions=+50% | GrowthEPS=+21.3% | GrowthRev=+18.5%
EPS next Year (2028-03-31): EPS=13.66 | Chg30d=+0.00% | Revisions=+44% | GrowthEPS=+8.5% | GrowthRev=+4.3%
[Analyst] Revisions Ratio: +37% (up=19, down=8)